Author:
Ali Rabyah B,Atangwho Item J,Kuar Navneet,Ahmad Mariam,Mahmud Roziahanim,Asmawi Mohd Z
Abstract
Abstract
Background
One vital therapeutic approach for the treatment of type 2 diabetes mellitus is the use of agents that can decrease postprandial hyperglycaemia by inhibiting carbohydrate digesting enzymes. The present study investigated the effects of bioassay-guided extract and fractions of the dried fruit pericarp of Phaleria macrocarpa, a traditional anti-diabetic plant, on α-glucosidase and α-amylase, in a bid to understand their anti-diabetic mechanism, as well as their possible attenuation action on postprandial glucose increase.
Methods
Methanol extract (ME), obtained by successive solvent extraction, its most effective liquid-liquid n-butanol fraction (NBF) and the flash column chromatographic sub-fraction (SFI), were evaluated for in vitro α-glucosidase (yeast) and α-amylase (porcine) activity inhibition. Furthermore, confirmatory in vivo tests were carried out in streptozotocin-induced diabetic rats (SDRs) using oral glucose, sucrose and starch tolerance tests.
Results
At the highest concentration employed (100 μg/ml), NBF showed highest inhibition against α-glucosidase (75%) and α-amylase (87%) in vitro (IC50 = 2.40 ± 0.23 μg/ml and 58.50 ± 0.13 μg/ml, respectively) in a dose-dependent fashion; an effect found to be about 20% higher than acarbose (55%), a standard α-glucosidase inhibitor (IC50 = 3.45 ± 0.19 μg/ml). The ME and SFI also inhibited α-glucosidase (IC50 = 7.50 ± 0.15 μg/ml and 11.45 ± 0.28 μg/ml) and α-amylase (IC50 = 43.90 ± 0.19 μg/ml and 69.80 ± 0.25 μg/ml), but to a lesser extent. In in vivo studies with diabetic rats, NBF and SFI effectively reduced peak blood glucose (PBG) by 15.08% and 6.46%, and the area under the tolerance curve (AUC) by 14.23% and 12.46%, respectively, after an oral sucrose challenge (P < 0.05); thereby validating the observed in vitro action. These reduction effects on PBG and AUC were also demonstrated in glucose and starch tolerance tests, but to a lesser degree.
Conclusions
These findings reveal that P. macrocarpa can attenuate hyperglycaemia in both in vitro and in vivo conditions by potently inhibiting carbohydrate hydrolysing enzymes, making it a viable plant for sourcing natural compounds for the management of type 2 diabetes mellitus.
Publisher
Springer Science and Business Media LLC
Subject
Complementary and alternative medicine,General Medicine
Reference25 articles.
1. Grover JK, Yadav S, Vats V: Medicinal plants of India with anti-diabetic potential. J Ethnopharmacol. 2002, 81: 81-100. 10.1016/S0378-8741(02)00059-4.
2. Samy RP, Gopalakrishnakone P: Current status of herbals and their future perspective. Nature Proceedings. [http://hdl.handle.net/10101/npre.2007.1176.1]
3. Houghton PJ: Synergy and polyvalence: paradigm to explain the activity of herbal products. Evaluation of herbal medicinal products. Edited by: Houghton PJ, Mukherjee PK. 2009, London: Pharmaceutical press, 85-94.
4. Shaw JE, Sicree RA, Zimmet PZ: : Global estimates of the prevalence of diabetes for 2010 and 2030. Diabet Res Clin Pract. 2010, 87: 4–-1 4.
5. Jelodar G, Maleki M, Sirus S: Effect of Walnut leaf, Coriader and Pomegranate on blood glucose and histopathology of pancreas of alloxan induced diabetic rats. Afr J Trad Compl Altern Med. 2007, 4: 299-305.
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献